193 related articles for article (PubMed ID: 31704598)
21. MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
Liu Y; Dong TF; Li PJ; Chen LB; Song T
Magn Reson Imaging; 2024 Jul; 110():170-175. PubMed ID: 38035947
[TBL] [Abstract][Full Text] [Related]
22. Fused deep learning paradigm for the prediction of o6-methylguanine-DNA methyltransferase genotype in glioblastoma patients: A neuro-oncological investigation.
Saxena S; Jena B; Mohapatra B; Gupta N; Kalra M; Scartozzi M; Saba L; Suri JS
Comput Biol Med; 2023 Feb; 153():106492. PubMed ID: 36621191
[TBL] [Abstract][Full Text] [Related]
23. Exploring MGMT methylation-driven structural connectivity changes in insular gliomas: a tractography and graph theoretical analysis.
Yang ZC; Yin CD; Yeh FC; Xue BW; Song XY; Li G; Sun SJ; Deng ZH; Hou ZG; Xie J
J Neurooncol; 2024 Jan; 166(1):155-165. PubMed ID: 38150062
[TBL] [Abstract][Full Text] [Related]
24. Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI.
Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Lei Y; Huang B
J Magn Reson Imaging; 2023 Nov; 58(5):1441-1451. PubMed ID: 36896953
[TBL] [Abstract][Full Text] [Related]
25. MRI-based radiomics signature and clinical factor for predicting H3K27M mutation in pediatric high-grade gliomas located in the midline of the brain.
Wu C; Zheng H; Li J; Zhang Y; Duan S; Li Y; Wang D
Eur Radiol; 2022 Mar; 32(3):1813-1822. PubMed ID: 34655310
[TBL] [Abstract][Full Text] [Related]
26. Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas.
Park CJ; Kim S; Han K; Ahn SS; Kim D; Park YW; Chang JH; Kim SH; Lee SK
Yonsei Med J; 2024 May; 65(5):283-292. PubMed ID: 38653567
[TBL] [Abstract][Full Text] [Related]
27. A logistic regression model for prediction of glioma grading based on radiomics.
Sun X; Liao W; Cao D; Zhao Y; Zhou G; Wang D; Mao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 46(4):385-392. PubMed ID: 33967085
[TBL] [Abstract][Full Text] [Related]
28. Coordinatized lesion location analysis empowering ROI-based radiomics diagnosis on brain gliomas.
Liu X; Zhang Q; Li J; Xu Q; Zhuo Z; Li J; Zhou X; Lu M; Zhou Q; Pan H; Wu N; Zhou Q; Shi F; Lu G; Liu Y; Zhang Z
Eur Radiol; 2023 Dec; 33(12):8776-8787. PubMed ID: 37382614
[TBL] [Abstract][Full Text] [Related]
29. Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study.
Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Yang W; Lei Y; Huang B
Neuroradiology; 2024 Jan; 66(1):81-92. PubMed ID: 37978079
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of using a multiparametric magnetic resonance imaging-based radiomics model to distinguish glioma recurrence from pseudoprogression.
Fu FX; Cai QL; Li G; Wu XJ; Hong L; Chen WS
Magn Reson Imaging; 2024 Sep; 111():168-178. PubMed ID: 38729227
[TBL] [Abstract][Full Text] [Related]
31. Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study.
Zhu HB; Zhu HT; Jiang L; Nie P; Hu J; Tang W; Zhang XY; Li XT; Yao Q; Sun YS
Eur Radiol; 2024 Jan; 34(1):90-102. PubMed ID: 37552258
[TBL] [Abstract][Full Text] [Related]
32. [Predicting cerebral glioma enhancement pattern using a machine learning-based magnetic resonance imaging radiomics model].
He H; Guo E; Meng W; Wang Y; Wang W; He W; Wu Y; Yang W
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):194-200. PubMed ID: 38293992
[TBL] [Abstract][Full Text] [Related]
33. A radiomics-based nomogram may be useful for predicting telomerase reverse transcriptase promoter mutation status in adult glioblastoma.
Li Y; Chen L; Huang L; Li X; Huang Q; Tang L; Huang Z; Zhu L; Li T
Brain Behav; 2024 May; 14(5):e3528. PubMed ID: 38798094
[TBL] [Abstract][Full Text] [Related]
34. MRI-based intratumoral and peritumoral radiomics for preoperative prediction of glioma grade: a multicenter study.
Tan R; Sui C; Wang C; Zhu T
Front Oncol; 2024; 14():1401977. PubMed ID: 38803534
[TBL] [Abstract][Full Text] [Related]
35. Diffusion Kurtosis Imaging Reflects Glial Fibrillary Acidic Protein (GFAP), Topo IIα, and O⁶-Methylguanine-DNA Methyltransferase (MGMT) Expression in Astrocytomas.
Wang XC; Lei Y; Wang L; Tan Y; Qin JB; Ma GL; Zhang H
Med Sci Monit; 2018 Dec; 24():8822-8830. PubMed ID: 30520434
[TBL] [Abstract][Full Text] [Related]
36. MR-based radiomics predictive modelling of EGFR mutation and HER2 overexpression in metastatic brain adenocarcinoma: a two-centre study.
Li Y; Jin Y; Wang Y; Liu W; Jia W; Wang J
Cancer Imaging; 2024 May; 24(1):65. PubMed ID: 38773634
[TBL] [Abstract][Full Text] [Related]
37. Do the combination of multiparametric MRI-based radiomics and selected blood inflammatory markers predict the grade and proliferation in glioma patients?
Guo J; Ren J; Shen J; Cheng R; He Y
Diagn Interv Radiol; 2021 May; 27(3):440-449. PubMed ID: 33769289
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric MRI radiomics for the differentiation of brain glial cell hyperplasia from low-grade glioma.
Gu S; Qian J; Yang L; Sun Z; Hu C; Wang X; Hu S; Xie Y
BMC Med Imaging; 2023 Aug; 23(1):116. PubMed ID: 37653513
[TBL] [Abstract][Full Text] [Related]
39. An Explainable MRI-Radiomic Quantum Neural Network to Differentiate Between Large Brain Metastases and High-Grade Glioma Using Quantum Annealing for Feature Selection.
Felefly T; Roukoz C; Fares G; Achkar S; Yazbeck S; Meyer P; Kordahi M; Azoury F; Nasr DN; Nasr E; Noël G; Francis Z
J Digit Imaging; 2023 Dec; 36(6):2335-2346. PubMed ID: 37507581
[TBL] [Abstract][Full Text] [Related]
40. Prediction of Fuhrman grade of renal clear cell carcinoma by multimodal MRI radiomics: a retrospective study.
Pan L; Chen M; Sun J; Jin P; Ding J; Cai P; Chen J; Xing W
Clin Radiol; 2024 Feb; 79(2):e273-e281. PubMed ID: 38065776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
